Navigation Links
Negative Emotions Could Lead To Stroke

Experiencing anger, strong negative emotions, or a sudden change in body position may increase an individual’s chances of having a stroke//, say researchers based on findings of a recent study .

The research is based on a survey conducted by 200 people who suffered an ischemic stroke or a transient ischemic attack (TIA), also known as a “mini-stroke.” These types of strokes, which are among the most common, occur when blood flow to the brain is reduced. All the participants were interviewed between one and four days after having the stroke to see if they had experienced any anger, strong emotions, or sudden change in body position prior to the stroke.

More than 30 percent of the group reported experiencing such events within a couple of hours before having their stroke. Thus it was observed that anger or strong negative emotions could increase the risk of stroke by about 14-times and a sudden change in body position after a startling event was linked to a 24-fold increased risk , however researchers say the increased risk is only for the two hours after the event occurs.

In conclusion researchers say the major risk factors for stroke continue to be smoking, high blood pressure, high cholesterol, and diabetes, but believe factors such as those identified in this study can contribute to the condition as well.
'"/>




Page: 1

Related medicine news :

1. Negative Impact Of Hepatitis C Infection In Renal Transplant Recipients
2. Negative Effects Of Sedatives
3. Woman Tests Negative For Japanese Encephalitis: Health Minister
4. Bird Flu Test Results Negative: India
5. Negative Effects of Asthma Can Be Countered With Personality changes
6. 21 Year Old Tests Negative for the Human Form Of Bird-Flu
7. Disney in Trouble? Negative Excitement in Disneyland, Paris
8. Negative religious Spirituality related to depression in physicians
9. Indonesian Traveler Tests Negative For Bird Flu, Singapore Safe
10. Chicken Samples Test Negative For Bird Flu In Chattisgarh
11. Symptoms In Dementia Patients Negatively Correlates With The Characteristics Of Caregivers
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Negative Emotions Could Lead Stroke

Other Medicine News:Health News:Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics 2Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 2Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 3Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 4Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 5Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 6Health News:Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees 7Health News:Former Pfizer Patent Attorneys Join Brinks Hofer Gilson & Lione 2Health News:Former Pfizer Patent Attorneys Join Brinks Hofer Gilson & Lione 3Health News:Jefferson researchers uncover new evidence of prolactin's possible role in breast cancer 2Health News:Scientific Publications Strategy & Delivery Shifts from Marketing to Medical 2Health News:Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Ranks in Deloitte's 2007 Washington State Technology 'Fast 50' for 4th Time in Past 6 Years 2Health News:Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Ranks in Deloitte's 2007 Washington State Technology 'Fast 50' for 4th Time in Past 6 Years 3Health News:Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Ranks in Deloitte's 2007 Washington State Technology 'Fast 50' for 4th Time in Past 6 Years 4
Breaking Medicine Technology:Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 2Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 3Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 4Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 3Ser Padres Joins Forces with la Doctora Alizas VidaySalud com to Offer the Hispanic Community Unprecedented Online Health Related Content in Spanish 49632 1Ser Padres Joins Forces with la Doctora Alizas VidaySalud com to Offer the Hispanic Community Unprecedented Online Health Related Content in Spanish 49632 2Ser Padres Joins Forces with la Doctora Alizas VidaySalud com to Offer the Hispanic Community Unprecedented Online Health Related Content in Spanish 49632 3Transcend Medical Raises 2435 Million Series B Round Towards Development of Novel Glaucoma Treatment 49630 1Transcend Medical Raises 2435 Million Series B Round Towards Development of Novel Glaucoma Treatment 49630 2DIA Annual Meeting Attendees Invited to Participate in Electronic Data Capture 28EDC 29 Clinical Trial Survey 4626 1DIA Annual Meeting Attendees Invited to Participate in Electronic Data Capture 28EDC 29 Clinical Trial Survey 4626 2
Other Medicine Technology:New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 2New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 3New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 4New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 5New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 6New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 7New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 8Siemens Corporate Research Develops RAPID2 System for Fast Discovery of Discriminative Pathogen Signatures 2